XML 40 R30.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue (Tables)
 9 Months Ended
Sep. 30, 2021
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue [Table Text Block] The following table represents our revenues disaggregated by geography (in thousands):
Three months ended
September 30,		Nine months ended
September 30,
Geography2021202020212020
Europe, the Middle East and Africa$36,239 $32,596 $108,800 $99,107 
Other Foreign54,523 48,525 169,667 175,618 
Total Foreign90,762 81,121 278,467 274,725 
United States245,298 237,446 697,316 675,828 
Total Revenues$336,060 $318,567 $975,783 $950,553 
    
    
    The following table represents our revenues disaggregated by product line (in thousands):
Three months ended
September 30,		Nine months ended
September 30,
Product line2021202020212020
Infusion Consumables$144,850 $116,054 $407,419 $350,554 
Infusion Systems90,688 88,388 259,683 267,856 
IV Solutions89,237 101,900 271,834 295,369 
Critical Care11,285 12,225 36,847 36,774 
Total Revenues$336,060 $318,567 $975,783 $950,553 
Contract with Customer, Asset and Liability [Table Text Block] The following table presents our changes in the contract balances for the nine months ended September 30, 2021 and 2020 (in thousands):
Contract Liabilities
Beginning balance, January 1, 2021$(6,430)
Equipment revenue recognized7,193 
Equipment revenue deferred due to implementation(8,652)
Software revenue recognized6,194 
Software revenue deferred due to implementation(2,967)
Ending balance, September 30, 2021$(4,662)
Beginning balance, January 1, 2020$(4,855)
Equipment revenue recognized9,920 
Equipment revenue deferred due to implementation(13,679)
Software revenue recognized4,715 
Software revenue deferred due to implementation(5,033)
Ending balance, September 30, 2020$(8,932)